Table 1.
Demographics and main clinical features of the study population
| Treatment group | Control group | P value | |
|---|---|---|---|
| Eyes (patients), no. | 15 (15) | 12 (12) | |
| Sex, no. | |||
| Male | 13 | 11 | |
| Female | 2 | 1 | 1.000a |
| Age, years (mean ± SD) | 44 ± 9 | 47 ± 11 | 0.493b |
| Duration of symptoms, weeks (mean ± SD) | 6.9 ± 3.1 | 6.3 ± 2.8 | 0.645b |
| BCVA, logMAR (mean ± SD) | 0.15 ± 0.12 | 0.12 ± 0.06 | 0.337b |
| CMT, µm (mean ± SD) | 426 ± 104 | 409 ± 113 | 0.693b |
| SRF, µm (mean ± SD) | 188 ± 107 | 171 ± 100 | 0.679b |
| Subfoveal CT, µm (mean ± SD) | 436 ± 78 | 378 ± 76 | 0.064b |
SD standard deviation, BCVA best-corrected visual acuity, CMT central macular thickness, SRF subretinal fluid, CT choroidal thickness
aFisher’s exact test, bStudent’s t test